In Person

19th Annual Pharmaceutical and Medical Device Compliance Congress

November 7 – 9, 2018
Event details
November 7 – 9, 2018
12:00 am
Washington, DC

Event summary

Cooley is sponsoring the 19th Annual Pharmaceutical and Medical Device Compliance Congress. Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from 50+ of the largest research-based pharmaceutical manufacturers.

Event details and registration >

Enter code "Grantor" for discounted rate on webcast and onsite attendance.

Featured agenda items

Day 2 – Thursday, November 8, 2018
11:00 am: Mini Summit VI: Advanced Strategies to Measure Effectiveness, Monitor and Report on Compliance Programs
Cooley partner Wendy Goldstein is a featured speaker.

Day 2 – Thursday, November 8, 2018
12:15 pm: Mini Summit IX: Interactions with Specialty Pharmacy
Cooley partner Sarah diFrancesca is a featured speaker.

Day 2 – Thursday, November 8, 2018
2:45 pm: Mini Summit XXIII: Compliance Considerations in Value-based Contracting
Cooley partner Wendy Goldstein is a featured speaker.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.